Qiqing Cai

No. 127, Dongming Road
Zhengzhou, 450008, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 21 publications

A Phase 1a/1b Dose Escalation/Expansion Study of the Anti-PD-1 Monoclonal Antibody Nofazinlimab in Chinese Patients with Solid Tumors or Lymphoma.

A Phase 1a/1b Dose Escalation/Expansion Study of the Anti-PD-1 Monoclonal Antibody Nofazinlimab in Chinese Patients with Solid Tumors or Lymphoma.

Journal: Targeted oncology

Published: August 14, 2024

Anlotinib for Recurrent or Metastatic Primary Malignant Bone Tumor: A Multicenter, Single-Arm Trial.

Anlotinib for Recurrent or Metastatic Primary Malignant Bone Tumor: A Multicenter, Single-Arm Trial.

Journal: Frontiers in oncology

Published: November 09, 2021

Osteosarcoma in One of Identical Twins: Three Cases Report and a Literature Review.

Osteosarcoma in One of Identical Twins: Three Cases Report and a Literature Review.

Journal: Orthopaedic surgery

Published: January 06, 2021

Activity and Safety of Geptanolimab (GB226) for Patients with Unresectable, Recurrent, or Metastatic Alveolar Soft Part Sarcoma: A Phase II, Single-arm Study.

Activity and Safety of Geptanolimab (GB226) for Patients with Unresectable, Recurrent, or Metastatic Alveolar Soft Part Sarcoma: A Phase II, Single-arm Study.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research

Published: July 20, 2020

Biological reconstruction in the treatment of extremity sarcoma in femur, tibia, and humerus.

Biological reconstruction in the treatment of extremity sarcoma in femur, tibia, and humerus.

Journal: Medicine

Published: July 08, 2020

Mid- to long-term effects of two different biological reconstruction techniques for the treatment of humerus osteosarcoma involving caput humeri.

Mid- to long-term effects of two different biological reconstruction techniques for the treatment of humerus osteosarcoma involving caput humeri.

Journal: World journal of surgical oncology

Published: August 16, 2019

Efficacy and safety of apatinib in treatment of osteosarcoma after failed standard multimodal therapy: An observational study.

Efficacy and safety of apatinib in treatment of osteosarcoma after failed standard multimodal therapy: An observational study.

Journal: Medicine

Published: May 15, 2019

Upregulation of ALDH1B1 promotes tumor progression in osteosarcoma.

Upregulation of ALDH1B1 promotes tumor progression in osteosarcoma.

Journal: Oncotarget

Published: August 21, 2017

LDHB may be a significant predictor of poor prognosis in osteosarcoma.

LDHB may be a significant predictor of poor prognosis in osteosarcoma.

Journal: American journal of translational research

Published: June 15, 2016

Treatment of osteosarcoma around the knee in skeletally immature patients.

Treatment of osteosarcoma around the knee in skeletally immature patients.

Journal: Oncology letters

Published: April 27, 2016

TRAF4 enhances osteosarcoma cell proliferation and invasion by Akt signaling pathway.

TRAF4 enhances osteosarcoma cell proliferation and invasion by Akt signaling pathway.

Journal: Oncology research

Published: February 21, 2015

Tumor necrosis factor-α- and interleukin-1β-dependent matrix metalloproteinase-3 expression in nucleus pulposus cells requires cooperative signaling via syndecan 4 and mitogen-activated protein kinase-NF-κB axis: implications in inflammatory disc disease.

Tumor necrosis factor-α- and interleukin-1β-dependent matrix metalloproteinase-3 expression in nucleus pulposus cells requires cooperative signaling via syndecan 4 and mitogen-activated protein kinase-NF-κB axis: implications in inflammatory disc disease.

Journal: The American journal of pathology

Published: April 18, 2014

Showing 1-12 of 21

Last Updated: 09/26/2026